Akira Tsukagawa CFA MBA
Founder CEO | Open Innovation Partners connecting Innovation to Japan
Tokyo, Japan
3K followers
500+ connections
About
Founder CEO of Open Innovation Partners connecting Innovation to Japan
Activity
3K followers
-
Akira Tsukagawa CFA MBA shared thisGene and microRNA and snoRNA will be more analyzed!
-
Akira Tsukagawa CFA MBA shared thisI tried OpenAI Chat many times and I got amazing answers from OpenAI. Microsoft 49% stake will give MS giant power but at the same time I hope this transaction can create more free innovation powers. Congratulations to Satya Nadella san.Akira Tsukagawa CFA MBA shared thisBREAKING: Microsoft Is In Talks To ACQUIRE A 49% Stake Worth $10 billion In ChatGPT Owner OpenAI — This Is A Big Deal 🤯 Microsoft would receive 75% of OpenAI’s income until it has recovered its initial investment, good terms for the tech giant. Once they hit that threshold, they would have a 49% stake in OpenAI, with other investors taking another 49% and OpenAI's nonprofit parent getting 2%. OpenAI is currently raising funds at a $29 billion valuation and is allowing employees along with early investors to sell their shares at the that valuation. Microsoft has already invested $1bn into the company in 2019. Open AI are expected to generate ~1 Billion in revenue in 2024. Microsoft will look to add OpenAI’s Chatbot, ChatGPT’s Artificial Intelligence tech to Bing, Word, Outlook, Excel and PowerPoint. MS office has 1.4 billions users worldwide 🤯 I believe this could end up one of the best tech deals of all-time, thinks WhatsApp/instagram. Satya Nadella masterclass! Boom! #investment #tech #instagram #artificialintelligence #microsoft #technology #finance #investing #ai
-
Akira Tsukagawa CFA MBA shared thisAmit san and Sanjay san, Capital raising is getting tough for start up especially for the ones in early stage. Great posting about phenomenon. Thank millions.Akira Tsukagawa CFA MBA shared thisRaising Capital in Times of Valuation Uncertainty At Tau Ventures, we remain bullish on AI deep tech companies and see tremendous opportunity to build enduring innovative companies in 2023. This year begins with a record amount of capital already raised by venture capital (VC) funds. According to SVB, VC/PE funds have $269 billion of dry powder (SVB, December 2022) waiting to be deployed. At the same time, valuation multiples have been changing significantly from 20x next twelve months revenue to 5x to 10x (TechCrunch, Jan 2023), causing some hesitation on how to price deals. For some startups, the result is rounds taking longer to close and yet a potential for a significant number of deals on the horizon. So how can startups move conversations to funding? Outlined below are a few tactics. 1. VIP & Channel Partners Round – Go back to investors who expressed interest in the last round, creating a "VIP" convertible note with a discount to a future round or slight markup to the last round's price. Second, bring channel partners on to the cap table. Channel partners that become investors may be more motivated to promote your product over other similar products. Third, consider asking early investors that don't do follow-ons to sell at the previous valuation and bring in a new investor with pro rata rights that tends to do follow-ons onto the cap table at the previous round's price. The change in mix of investors can bring new networks to the company's investor base. 2. Tranche Deals – Raise capital in two tranches in which part of the commitment from an investor comes in a first close and the remainder comes in a second close after an achievable milestone. These transactions tend to be common in the health care industry where approvals such as FDA or 510K clearances are clearly defined milestones. Yet, the same approach can be used in other industries where milestones could include product availability, closing customers, number of trial customers, retention, login rates, and so forth. 3. Variable Valuations – Variable valuations can be helpful in situations where the valuation is set for example based on the end of quarter performance or first half of the year performance. In certain cases, a startup's revenue prospects may change significantly as a pipeline converts from prospects to customers or an acquisition is completed. Tau Ventures is an early stage venture fund. This article is purposely meant to be a short resource to start conversations. [1] https://lnkd.in/ggUGK9Hb [2] https://lnkd.in/gDZZwPTd cc: Tau Ventures
-
Akira Tsukagawa CFA MBA shared thisStanford University Inauguration Speech 2018 was Tim Cook succeeding apple and Stanford Inauguration both!Akira Tsukagawa CFA MBA shared this"There are too many people who want credit without responsibility. Too many who show up for the ribbon cutting without building anything worth a damn. Be different. Leave something worthy. And always remember that you can’t take it with you. You’re going to have to pass it on." -Apple CEO Tim Cook at #Stanford19
-
Akira Tsukagawa CFA MBA shared thisF Mrord g K. GWe M Sem Mr k Ki K I k Rtf K wm K F fm G memt Pe. K K
-
Akira Tsukagawa CFA MBA liked thisAkira Tsukagawa CFA MBA liked thisA partnership built to make digital commerce more seamless. 🤝 We’re excited to announce our partnership with CCAvenue, signed at Global Fintech Fest bringing together fastrr By Shiprocket’s e-commerce capabilities with CCAvenue’s secure and seamless payment infrastructure. This collaboration is focused on helping businesses simplify their payment journey, streamline operations, and create a smoother experience for their customers. It was great to mark this milestone at one of the leading platforms for fintech innovation and collaboration. Here’s to building smarter, simpler, and more connected commerce experiences. 🚀 fastrr By Shiprocket × CCAvenue | Building what’s next in digital commerce. Pankaj Dedhia | Gaurav Mangla | Manuj Mundra | Saurabh Sarkar | Nishant Kumar Nitesh | pranjal pandey | Rahul Misra | Vivek Patel | Vineeta Edward D'Almeida #ccavenue #partnership #paymentpartnership #fastrrbyshiprocket #GFF #globalfintechfest
-
Akira Tsukagawa CFA MBA liked thisAkira Tsukagawa CFA MBA liked thisPlanning to expand or invest in Germany? Berlin Partner supports international companies with location consulting, funding guidance and access to strong local networks – free and confidential.
-
Akira Tsukagawa CFA MBA liked thisAkira Tsukagawa CFA MBA liked thisSpending the next two nights in Southwark, on the south bank of the River Thames. Today, I enjoyed a walk along the Thames, making my way to The Shard. The view from the 31st floor was simply breathtaking.
-
Akira Tsukagawa CFA MBA liked thisAkira Tsukagawa CFA MBA liked thisIt’s here. AI Native eBook + Audiobook are live today. https://www.ainativebook.com/ If you’re thinking about how AI will reshape your company, your work, and the future, I hope you’ll give it a read/listen. #AInative #AItransformation #EnterpriseAI
-
Akira Tsukagawa CFA MBA liked thisCongratulations to the 2026 IA40 winners, including March Capital portfolio company Together AI! CC: MadronaAkira Tsukagawa CFA MBA liked thisThe 2026 Intelligent Applications 40 is here. Now in its sixth year, the IA40 recognizes the top private companies shaping the future of applied AI, from foundational infrastructure to full-stack intelligent applications. This year's list reflects a market maturing fast: → 450+ companies nominated and voted on by 72 investors across 54 leading firms → $410B raised by this year's 45 winners since founding — more than 25x what the inaugural 2021 class had raised at the same point → 23 repeat winners and 22 new entrants, a 49% turnover rate, down from 68% last year, as some of 2025's breakout companies start to entrench The big pattern this year is how companies are “Harnessing the Value of AI.” As frontier models become more capable and commoditized, the winners are increasingly the companies proving they can turn AI capability into real ROI, whether they're building the application, aggregating the models, or supplying the infrastructure underneath. Databricks remains the only company to appear on every IA40 list since we launched it in 2021. Congratulations to all the 2026 IA40 winners. Your work is defining what's possible in this new era of intelligent applications. Explore all 45 winners and our analysis of the companies, categories, and funding patterns defining this year’s list → ordnl.link/RAFgnA7 Thank you to our great partners: Amazon Web Services (AWS), Google for Startups, Microsoft, NYSE, Delta Air Lines, and McKinsey & Company.
-
Akira Tsukagawa CFA MBA liked thisAkira Tsukagawa CFA MBA liked thisOur portfolio company TOWING has partnered with Kanematsu on an initiative to supply Chikaranomoto Company, the operator of the Ippudo ramen chain, with both domestically produced rice from farmers in Ogata Village, Akita Prefecture, and the environmental value generated through its production in the form of J-Credits. What makes this initiative notable is that it goes beyond simply reducing carbon emissions. The greenhouse gas reductions achieved through the application of biochar to farmland are converted into J-Credits and then integrated into the actual supply chain as a form of environmental value. Under the initiative, Kanematsu supplies the rice while ensuring traceability, and Chikaranomoto covers part of the cost incurred by farmers in adopting biochar. TOWING supplies the biochar and also handles the generation and retirement of the associated J-Credits. This creates a mechanism that connects farmers’ efforts to reduce environmental impact with downstream demand by translating those efforts into measurable environmental value. We hope to see this kind of model expand further, with domestically produced food increasingly chosen together with the environmental value created through its production. https://towing.co.jp/en
-
Akira Tsukagawa CFA MBA liked thisAkira Tsukagawa CFA MBA liked thisThank you for AIM Congress, Faisal Hamady and my fellow panelists for such an epic session on all things AI - what an epic conversation and opportunity for SeKondBrain.ai #AI #Polymaths
-
Akira Tsukagawa CFA MBA liked thisAkira Tsukagawa CFA MBA liked thisA heartfelt thank you to Arihant Patni, Managing Director, 𝐏𝐚𝐭𝐧𝐢 𝐅𝐚𝐦𝐢𝐥𝐲 𝐎𝐟𝐟𝐢𝐜𝐞, and Rajan Mehra, Partner, March Capital, for their insightful session on 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠 𝐢𝐧 𝐀𝐈 – 𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐒𝐭𝐚𝐜𝐤, 𝐍𝐨𝐭 𝐭𝐡𝐞 𝐇𝐲𝐩𝐞 at the 8𝐭𝐡 𝐈𝐧𝐝𝐢𝐚𝐧 𝐅𝐚𝐦𝐢𝐥𝐲 𝐀𝐥𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐯𝐞 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐅𝐨𝐫𝐮𝐦. As AI moves rapidly from emerging technology to a powerful force across industries, the session offered valuable perspectives on looking beyond the excitement around AI and understanding where sustainable investment opportunities may lie. The discussion explored the AI ecosystem, from its underlying infrastructure and data foundations to platforms and applications, while considering what separates lasting opportunities from short-term hype. We are truly grateful to Arihant and Rajan for their expertise and contribution to a conversation that offered a thoughtful perspective. 📧 To learn more, write to us at: info@campdenfamilyconnect.com 🌐 Visit: campdenfamilyconnect.com ... #CampdenFamilyConnect #IndianFamilyAlternativeInvestmentForum #InvestingInAI #AIInvesting #ArtificialIntelligence #AIInnovation #AIEcosystem #AIInfrastructure #VentureCapital #FamilyOffice #FamilyCapital #AlternativeInvestments #PrivateCapital #InvestmentStrategy #PrivateMarkets #TechnologyInvesting #FutureOfAI #PortfolioStrategy #LongTermInvesting #CapitalStewardship
Experience
-
Open Innovation Partners
-
Founder CEO
Open Innovation Partners
-
Advisor of Sompo Holdings for Open Innovation
Open Innovation Partners
-
-
Country Head for Japan
miR Scientific, LLC
-
Director for Japan
Miraki Innovation
-
Co Founder
Seize Capital
-
Co Founder
C/Mission Pte Ltd
-
CEO
Muroc Inc
-
Advisor for Business Development for India
Recruit Holdings
-
Representative for India
SBI holdings
-
Vice President
NOMURA/ JAFCO INVESTMENT ASIA
Education
-
University of California, Berkeley, Haas School of Business
Executive Education in Data Science & Analytics Data Science Certificate of Excellence
-
-
University of California, Berkeley, Haas School of Business
Certificate of Excellence Executive Education focusing on Innovation, Open Innovation, and Venture Capital
-
May 6-10, 2013: Venture Capital Executive Program
October 28-29, 2013: Corporate Business Model Innovation Program
October 27-31, 2014: The Innovative Organization Program
May 18-21, 2015: Strategy in Competitive Markets Program
October 20-22, 2015: Insider Entrepreneurship
Licenses & Certifications
-
CFA
-
Other similar profiles
Explore more posts
-
AI Tech Supports
Rlwrld, a Seoul, South Korea–based Physical #AI company developing robotics foundation models, has raised $26M in Seed funding. The round saw participation from Headline Asia, Z Venture Capital, CJ Logistics, KakaoInvestment (카카오인베스트먼트), Lotte Ventures, Hanwha Asset Management, Mirae Asset – Emart Investment Fund I, 효성벤처스 (Hyosung Ventures), Smilegate Investment, T Investment, and Hashed Ventures. The latest raise brings Rlwrld’s total funding to $26M, following an earlier $15M Seed 1 round led by Hashed Ventures. The company plans to use the capital to expand operations and accelerate development efforts. Led by CEO and Founder Junghee Ryu, RLWRLD is building real-world intelligence through robotics foundation models designed to deliver human-level dexterity and perception. Its scalable, multi-sensor system captures complex demonstrations across diverse industrial environments, generating rich datasets that power adaptable, generalizable models. Rlwrld expects to officially launch its robotics foundation model in the first half of 2026. #Funding #SeedRound #PhysicalAI #Robotics #FoundationModels #DeepTech #StartupNews #AITechSupports #AITech #AITechnology #CEO #CTO
-
KoreaTechDesk
Precision oncology is entering a faster, fairer era — and Korea is helping lead it. 💡 U.S.-based Acurion, Inc., led by CEO Rick Fultz, is transforming cancer diagnostics through AI-powered genomic insight. Its flagship technology, OncoGaze™, identifies HRD-positive patients up to 3x faster than conventional NGS testing — cutting weeks off diagnosis time. Through K-Startup Grand Challenge (KSGC) 2025, Acurion accelerated its expansion into Korea’s precision oncology ecosystem, securing partnerships with leading hospitals, investors, and regulators. KoreaTechDesk explores how Acurion’s collaboration under KSGC exemplifies the fusion of AI innovation, healthcare equity, and Korea’s growing role in global medical technology. 👉 https://lnkd.in/gg7Yjg8N But how do you think AI can make personalized medicine more accessible worldwide? 🤔 #KStartup #KSGC2025 #HealthTech #PrecisionOncology #AIinHealthcare #KoreaTechDesk
-
AMPulse Online
🚀 Startup Spotlight 🚀 Huaqing Zhimei - A high-tech biotechnology firm specializing in the industrialization of Bio-3D printing and human-engineered extracellular matrix (hEECM) materials for regenerative medicine and medical aesthetics. 🔍 Company Overview - CEO: Liu Boxun - Year Founded: 2021 - Location: Shenzhen, China - Team Size: 51-100 - Webpage: https://www.hmcell.com 🎯 What They Do - One-line Description: A high-tech biotechnology firm specializing in the industrialization of Bio-3D printing and human-engineered extracellular matrix (hEECM) materials for regenerative medicine and medical aesthetics. - Target Customers: Medical aesthetics clinics, dermatology hospitals, plastic surgery centers, and pharmaceutical research institutions. - Industry Verticals: Materials 🚀 Achievements & Status - Current Stage/Status: Post-Series A commercialization; operating a 2,000sqm GMP-standard production facility in Shenzhen with established product lines in the medical aesthetics market. - Major Milestones: Series A - Key Investors: Established the first national industry standard for ECM in China (2023),Successful launch of the 'Meibiyuan' (美泌源) high-end regenerative aesthetics brand,Completion of a 2,000sqm GMP bioactive material production line in Shenzhen (2024),Series A funding round of tens of millions of CNY (June 2024) - Basic Growth Metrics: Operating a 2,000-square-meter GMP-standard production facility in Shenzhen; established the first national industry standard for Extracellular Matrix (ECM) in China. 💡 Competitive Edge - How They Differentiate: Huaqing Zhimei differentiates through its 'Super Cell Factory' model. Unlike competitors who focus on recombinant single-protein collagen (expressed in yeast/E.coli), Huaqing Zhimei uses proprietary Bio-3D printing to create structured environments where human cells secrete a complete 'Human Engineered Extracellular Matrix' (hEECM) containing over 1,000 types of active proteins, achieving 100% bio-homology. - Key Technological Advantage: Pioneered the transition from 'printing organs' (long-term research) to 'printing factories' (immediate commercialization), solving the scalability and cost issues of high-purity human-derived bioactive materials. 📈 Funding & Partnerships - Total Funding Raised: $6.2M - Latest Funding Round: Series A - Key Investors: Leaguer Capital (力合创投),Shaanxi Financial Holding (陕西金控),Zijing Hongxin (紫荆泓鑫) - Key Partnerships/Collaborations: Research Institute of Tsinghua University in Shenzhen (Founding incubator),Shenzhen Young Science and Technology Association,Leaguer Capital (Investment & strategic ecosystem partner),Various Top-tier Class-A hospitals in China for clinical research Based on database updated on: 2026-01-14T15:37:45.074+09:00 #Innovation #AM #3Dprinting Powered by #WeeklyVentures "Spot an error? Share your feedback to help us improve!" https://lnkd.in/dhJVjbyH
-
Qiming Venture Partners
Qiming Venture Partners' portfolio company UBTECH Robotics (SEHK:9880) announced that its smart logistics subsidiary UQI has signed a procurement contract with Miracle Automation for its Walker S industrial humanoid robots, with a total value of RMB 30 million. Delivery is scheduled to be completed by December 31, 2025. With this milestone, contracts for the Walker humanoid robot series have reached nearly RMB 430 million to date (excluding orders for the full-sized research and education humanoid robot Tien Kung), including about RMB 50 million delivered in the first half of 2025. In September, UBTECH also secured a RMB 250 million agreement with a leading Chinese company for embodied AI humanoid robots and solutions, the largest single humanoid robotics contract worldwide to date. #HumanoidRobotics #EmbodiedAI #IndustrialAutomation #Innovation #QimingPortfolio #QimingTechnology
-
Global Bio & Investment Monthly
The convergence of AI, robotics, and medical imaging is reshaping healthcare—and creating new opportunities for Taiwan to connect with the global MedTech ecosystem. Amed Ventures has completed fundraising for its third fund (Fund III) at NT$3.2 billion, expanding its investment strategy across next-generation medical technologies. 🌐 Building stronger international connections According to Michael Wang , Chairman / Executive Managing Partner, Amed Ventures, Taiwan can leverage its strengths in precision manufacturing, semiconductors, sensors, and AI infrastructure, while connecting with technologies already backed by clinical evidence in the U.S. and Europe. The goal: combine “Made in Taiwan + international clinical evidence” to enter global supply chains and healthcare ecosystems. 🚀 Investing in next-generation MedTech William Tai, Founder & Managing Partner of Amed Ventures, highlighted AI, image-guided navigation, surgical robotics, and medical device CDMO as key areas for Fund III. AMED Ventures has already invested in more than 20 companies through its first two funds, bridging international medical innovation with Taiwan’s manufacturing capabilities. 📅 2026 AMED Ventures International Medical Forum “Redefining Healthcare: A New Generation of Clinical Therapy Driven by AI, Robotics, and Medical Imaging” will take place in Taipei on September 10, 2026, bringing together perspectives from clinical medicine, technology, and investment. Read More: https://reurl.cc/Z8ZEXV ➤ Follow us for more news and Taiwan biotech ecosystem updates: https://lnkd.in/gPb8fyrt #Globalbio #MedTech #HealthcareInnovation #MedicalDevices #AI #MedicalRobotics #MedicalImaging #TaiwanBiotech
1 Comment -
Korea Biomedical Review
Korea’s healthcare AI sector is rapidly advancing, led by companies such as Lunit Cancer Screening, Technology Seers, VUNO Inc., JLK, NOUL Co., Ltd., and SELVAS AI (SELVAS Healthcare, Inc.), which are expanding globally with AI-powered diagnostic and digital health solutions. https://lnkd.in/gQdi4v2U
-
Ryosuke Kimura
At BioJapan 2025, UTokyo IPC demonstrated Japan’s evolving university-based venture ecosystem. Two seminars explored the intersection of AI drug discovery, cross-border capital, and exit pathways — highlighting how academic innovation in Japan can compete globally. For investors and ecosystem builders, UTokyo IPC’s presence signaled that Japan’s biotech entrepreneurship is maturing, blending research excellence with practical commercialization strategies. It’s encouraging to see Japanese universities building bridges with the global biotech community — one step closer to making academic innovation an engine for growth. #BioJapan2025 #Biotech #AI #VentureCapital #UniversityInnovation Details: https://lnkd.in/gkGG79Wz
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More